An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Drug Acquiring Traction Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer laws, risking penalties, legal action or prison.
Service Response and Content Removal
According to TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.
After minutes of entering one community, a seller posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or past usage.
Product Information and Costs
Within these groups, messages show black plastic packages with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to possibly significant health risks”.
